{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:14Z","timestamp":1777984334429,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04836-x","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:05:40Z","timestamp":1771347940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multicenter prospective real-world cohort study of direct oral anticoagulant use for venous thromboembolism prophylaxis in nephrotic syndrome"],"prefix":"10.1186","volume":"27","author":[{"given":"Priti","family":"Meena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip Kumar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Kandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh Srinivasa","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinant","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash","family":"Khandelia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Malviya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikunj Kishore","family":"Rout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paromita","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anish","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badari","family":"Mylliemngap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prity","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"3","key":"4836_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2215\/CJN.10131011","volume":"7","author":"BA Kerlin","year":"2012","unstructured":"Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;7(3):513\u201320.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4836_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12882-024-03704-w","volume":"25","author":"YM Liu","year":"2024","unstructured":"Liu YM, Gao S, Liu LJ. The risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels: a study over 10 years. BMC Nephrol. 2024;25(1):301. https:\/\/doi.org\/10.1186\/s12882-024-03704-w.","journal-title":"BMC Nephrol"},{"issue":"2","key":"4836_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10157-015-1149-4","volume":"20","author":"SJ Li","year":"2016","unstructured":"Li SJ, Tu YM, Zhou CS, Zhang LH, Liu ZH. Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome. Clin Exp Nephrol. 2016;20(2):212\u20137.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"4836_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/ki.2011.312","volume":"81","author":"SJ Barbour","year":"2012","unstructured":"Barbour SJ, Greenwald A, Djurdjev O, Levin A, Hladunewich MA, Nachman PH, Hogan SL, Cattran DC, Reich HN. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2012;81(2):190\u20135. https:\/\/doi.org\/10.1038\/ki.2011.312. Epub 2011 Sep 14. PMID: 21918501.","journal-title":"Kidney Int"},{"issue":"4","key":"4836_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease","year":"2021","unstructured":"Kidney Disease. Improving global outcomes glomerular diseases work G. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):S1\u2013276.","journal-title":"Kidney Int"},{"issue":"6","key":"4836_CR6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/ki.2013.476","volume":"85","author":"T Lee","year":"2014","unstructured":"Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, Tannous S, et al. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney Int. 2014;85(6):1412\u201320.","journal-title":"Kidney Int"},{"issue":"1","key":"4836_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000448628","volume":"135","author":"AJ Rankin","year":"2017","unstructured":"Rankin AJ, McQuarrie EP, Fox JG, Geddes CC, MacKinnon B. Scottish renal biopsy registry. Venous thromboembolism in primary nephrotic syndrome - Is the risk high enough to justify prophylactic. Anticoagulation? Nephron. 2017;135(1):39\u201345.","journal-title":"Anticoagulation? Nephron"},{"issue":"5","key":"4836_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.amjmed.2021.11.018","volume":"135","author":"SV Vestergaard","year":"2022","unstructured":"Vestergaard SV, Birn H, Darvalics B, Nitsch D, S\u00f8rensen HT, Christiansen CF. Risk of arterial Thromboembolism, venous thromboembolism, and bleeding in patients with nephrotic syndrome: a population-based cohort study. Am J Med. 2022;135(5):615\u2013e6259. https:\/\/doi.org\/10.1016\/j.amjmed.2021.11.018.","journal-title":"Am J Med"},{"issue":"3","key":"4836_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1148\/radiol.14140121","volume":"273","author":"LJ Zhang","year":"2014","unstructured":"Zhang LJ, Zhang Z, Li SJ, Meinel FG, Nance JW Jr, Zhou CS, Zhao YE, Schoepf UJ, Lu GM. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology. 2014;273(3):897\u2013906.","journal-title":"Radiology"},{"issue":"10","key":"4836_CR10","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1016\/j.ekir.2024.07.013","volume":"9","author":"DM Azarniouch","year":"2024","unstructured":"Azarniouch DM, Crona DJ, Karnabi P, Bose B, Nachman PH, Carrier M, Canney M, Johnson DW, Lee T, Ramachandran R, Jha V, Key NS, Derebail VK. Anticoagulation for the prevention of thrombotic events in nephrotic syndrome. Kidney Int Rep. 2024;9(10):3053\u20136.","journal-title":"Kidney Int Rep"},{"issue":"11","key":"4836_CR11","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Subcommittee on control of A. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119\u201326.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"4836_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"AP Carnicelli","year":"2022","unstructured":"Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Cecilia Bahit M, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, Fox AA, Gencer K, Halperin B, Hijazi JL, Hohnloser Z, Hua SH, Hylek K, Toda Kato E, Kuder E, Lopes J, Mahaffey RD, Oldgren KW, Piccini J, Ruff JP, Steffel CT, Wojdyla J, Granger D. COMBINE AF (A collaboration between multiple institutions to better investigate Non-Vitamin K antagonist oral anticoagulant use in atrial Fibrillation) Investigators. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: Patient-Level network Meta-Analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022;145(4):242\u201355. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056355.","journal-title":"Circulation"},{"issue":"1","key":"4836_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ekir.2024.10.016","volume":"10","author":"NW Lange","year":"2024","unstructured":"Lange NW, Muir J, Salerno DM. Direct oral anticoagulants in patients with ESRD and kidney transplantation. Kidney Int Rep. 2024;10(1):40\u201353. https:\/\/doi.org\/10.1016\/j.ekir.2024.10.016. PMID: 39810765; PMCID: PMC11725803.","journal-title":"Kidney Int Rep"},{"key":"4836_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s11239-020-02092-w","volume":"50","author":"E Wojakowski","year":"2020","unstructured":"Wojakowski E, Cheruvil C, Hassan A, et al. Albumin and bleed risk in rivaroxaban treated patients. J Thromb Thrombolysis. 2020;50:1004\u201311. https:\/\/doi.org\/10.1007\/s11239-020-02092-w.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"4836_CR15","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.ekir.2025.01.042","volume":"10","author":"C Arches","year":"2025","unstructured":"Arches C, Jalal-Eddine A, Titeca-Beauport D, Dao M, Lobbedez T, Zaoui P, Masset C, Bertrand D, El Karoui K, Brenier H, Sakhi H, Peiffer B, Audard V, Joher N. Safety and efficacy of oral direct factor Xa inhibitors in patients with nephrotic syndrome: results from a National retrospective study. Kidney Int Rep. 2025;10(4):1188\u201395. https:\/\/doi.org\/10.1016\/j.ekir.2025.01.042.","journal-title":"Kidney Int Rep"},{"issue":"7","key":"4836_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/10600280221129348","volume":"57","author":"A Tijani","year":"2023","unstructured":"Tijani A, Coons EM, Mizuki B, Dermady M, Stanilova K, Casey AL, Alqudsi M, Gastanaduy M, Elmayan A, Bamnolker A, Velez JCQ. Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in patients with nephrotic syndrome: a retrospective cohort study. Ann Pharmacother. 2023;57(7):787\u201394. https:\/\/doi.org\/10.1177\/10600280221129348.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"4836_CR17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.ekir.2025.02.028","volume":"10","author":"E Cubilier","year":"2025","unstructured":"Cubilier E, Chergui Y, Garrouste C, Ramos I, Philipponnet C, Atenza A, Greze C, Aniort J, Uro-Coste C, Heng AE. Nephrotic syndrome thromboprophylaxis with direct oral anticoagulants or vitamin K antagonists. Kidney Int Rep. 2025;10(5):1468\u201375.","journal-title":"Kidney Int Rep"},{"key":"4836_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.ajkd.2022.09.011","volume":"81","author":"VK Derebail","year":"2023","unstructured":"Derebail VK, Zhu J, Crawford ML, et al. Pharmacokinetics and pharmacodynamics of Apixaban in nephrotic syndrome: findings from a phase 1a trial. Am J Kidney Dis. 2023;81:373\u20136. https:\/\/doi.org\/10.1053\/j.ajkd.2022.09.011.","journal-title":"Am J Kidney Dis"},{"key":"4836_CR19","doi-asserted-by":"publisher","unstructured":"Ramachandran R, Prabhahar A, Meena P, Priyamvada PS, Yadav K, Kohli HS, et al. Apixaban in primary membranous nephropathy - report from the iTANGIBLE registry. Indian J Nephrol. https:\/\/doi.org\/10.25259\/IJN_58_2025","DOI":"10.25259\/IJN_58_2025"},{"key":"4836_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3892\/etm.2017.5471","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang L, Zhang H, Zhang J, et al. Rivaroxaban for the treatment of venous thromboembolism in patients with nephrotic syndrome and low AT-III: a pilot study. Exp Ther Med. 2018;15:739\u201344. https:\/\/doi.org\/10.3892\/etm.2017.5471.","journal-title":"Exp Ther Med"},{"key":"4836_CR21","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.122.062752","volume":"147","author":"J Harrington","year":"2023","unstructured":"Harrington J, Carnicelli AP, Hua K, et al. Direct oral anticoagulants versus warfarin across the spectrum of kidney function: patient-level network meta-analyses from COMBINE AF. Circulation. 2023;147:1748\u201357. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062752.","journal-title":"Circulation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04836-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04836-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04836-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:45:49Z","timestamp":1774431949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04836-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4836"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04836-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8231240\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A written well informed Consent was taken from all the involved participants before enrolment in the study. The study was done in accordance with the Declaration of Helsinki has and been approved by the institutional ethics committee of all the participating centres. Institutional Ethical committee of All India medical sciences-Bhubaneswar, India being the co-ordinator centre provided primary ethical approval for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study contain no identifying images or other personal or clinical details of participants are presented that compromise anonymity. A written well informed Consent was taken from all the involved participants before enrolment in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}